LCM
CELL

Legato Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Legato Capital Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,872
Closed -$353K – 345
2021
Q2 		$353K Buy
+7,872
New +$365K 0.05% 301

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legato Capital Management's CELL Position: Q3 2021 in Review

Legato Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 7,872 shares — an estimated $353K sold.

Legato Capital Management first reported a position in CELL in Q2 2021 and held it in 1 quarter. The position peaked at $353K in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Legato Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Legato Capital Management sold 7,872 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $353K.
  • Legato Capital Management first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Legato Capital Management's PhenomeX Inc. Common Stock position peaked at $353K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Legato Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.